Catalog Home Page

Publications: Aung-Htut, May

Stats for Aung-Htut, May
Export as [feed] RSS
Group by: Item Type | Year
Number of items: 7.

Journal Article

Aung-Htut, M.T., McIntosh, C.S., West, K.A., Fletcher, S. and Wilton, S.D. (2019) In Vitro Validation of Phosphorodiamidate Morpholino Oligomers. Molecules, 24 (16). p. 2922.

Aung-Htut, M.T., Comerford, I., Johnsen, R., Foyle, K., Fletcher, S. and Wilton, S.D. (2019) Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides. Scientific Reports, 9 (1).

Aung-Htut, M.T., McIntosh, C.S., Ham, K.A., Pitout, I.L., Flynn, L.L., Greer, K., Fletcher, S. and Wilton, S.D. (2019) Systematic approach to developing splice modulating antisense oligonucleotides. International Journal of Molecular Sciences, 20 (20). Article 5030.

Aung-Htut, M.T., West, K., Barrett, L., Cardwell, K., Schnell, F.J., Fletcher, S. and Wilton, S.D. (2018) Late onset Pompe disease: Rescue of acid alpha-glucosidase expression by splice modification. Journal of Gene Medicine, 20 (1).

McIntosh, C.S., Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2018) The use of antisense oligonucleotide-mediated exon skipping to treat spinocerebellar ataxia type 3. Journal of Gene Medicine, 20 (1).

Chakravarthy, M., Aung-Htut, M.T., Le, B.T. and Veedu, R.N. (2017) Novel Chemically-modified DNAzyme targeting Integrin alpha-4 RNA transcript as a potential molecule to reduce inflammation in multiple sclerosis. Scientific Reports, 7 (1).

Fraidenraich, D., Toh, Z.Y.C., Aung-Htut, M.T., Pinniger, G., Adams, A.M., Krishnaswarmy, S., Wong, B.L., Fletcher, S. and Wilton, S.D. (2016) Deletion of dystrophin In-Frame Exon 5 leads to a severe phenotype: Guidance for Exon skipping strategies. PloS one, 11 (1). e0145620.

This list was generated on Thu Oct 17 22:33:23 2019 UTC.